Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Metaba","sponsor":"MAX BioPharma","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies","therapeuticArea":"Hepatology (Liver, Pancreatic, Gall Bladder)","highestDevelopmentStatus":"Preclinical","country":"U.S.A","productType":"Small molecule","productStatus":"New Molecular Entity","date":"February 2024","url1":"","url2":"","graph1":"Hepatology (Liver, Pancreatic, Gall Bladder)","graph2":"Preclinical"}]

    Find Clinical Drug Pipeline Developments & Deals by Metaba

    Menu

    Metaba

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Metaba

              Contact Supplier
              • Deals
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag U.S.A
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies

              Details:

              The collaboration aims to focus on the development of Oxy210 (oxysterol), a small-molecule antifibrotic. It is currently being evaluated in preclinical studies for the treatment of non-alcoholic steatohepatitis idiopathic, pulmonary fibrosis including chronic inflammation.

              Lead Product(s): Oxysterol

              Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Product Name: Oxy210

              Highest Development Status: Preclinical Product Type: Small molecule

              Partner/Sponsor/Collaborator: MAX BioPharma

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Collaboration February 26, 2024

              ASK
              US
              PHARMACOMPASS
              Upload
              your Pipeline Activity
              Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.
              Temad- We think of world-class quality.
              Post Enquiry
              POST ENQUIRY